|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 11 October 2006
doi: 10.1242/dev.02647
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Organogenesis and Neurogenesis Group, Center for Developmental Biology, RIKEN,
Kobe 650-0047, Japan.
2 Laboratory for Animal Resources and Genetic Engineering, Center for
Developmental Biology, RIKEN, Kobe 650-0047, Japan.
3 Department of Biochemistry and Molecular Biology, M. D. Anderson Cancer
Center, University of Texas, Houston, TX 77030, USA.
* Author for correspondence (e-mail: sasaicdb{at}mub.biglobe.ne.jp)
Accepted 8 September 2006
We here report essential roles of the Bmp-binding protein crossveinless 2 (Cv2; Bmper) in mouse organogenesis. In the null Cv2 mutant mouse, gastrulation occurs normally, but a number of defects are found in Cv2-expressing tissues such as the skeleton. Cartilage differentiation by Bmp4 treatment is reduced in cultured Cv2-/- fibroblasts. Moreover, the defects in the vertebral column and eyes of the Cv2-/- mouse are substantially enhanced by deleting one copy of the Bmp4 gene, suggesting a pro-Bmp role of Cv2 in the development of these organs. In addition, the Cv2-/- mutant exhibits substantial defects in Bmp-dependent processes of internal organ formation, such as nephron generation in the kidney. This kidney hypoplasia is synergistically enhanced by the additional deletion of Kcp (Crim2) which encodes a pro-Bmp protein structurally related to Cv2. This study demonstrates essential pro-Bmp functions of Cv2 for locally restricted signal enhancement in multiple aspects of mammalian organogenesis.
Key words: Crossveinless 2 (Bmper), Mouse, Organogenesis, Gene targeting, Crim2
This article has been cited by other articles:
![]() |
J. Heinke, L. Wehofsits, Q. Zhou, C. Zoeller, K.-M. Baar, T. Helbing, A. Laib, H. Augustin, C. Bode, C. Patterson, et al. BMPER Is an Endothelial Cell Regulator and Controls Bone Morphogenetic Protein-4-Dependent Angiogenesis Circ. Res., October 10, 2008; 103(8): 804 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Harada, A. Ogai, T. Takahashi, M. Kitakaze, H. Matsubara, and H. Oh Crossveinless-2 Controls Bone Morphogenetic Protein Signaling during Early Cardiomyocyte Differentiation in P19 Cells J. Biol. Chem., September 26, 2008; 283(39): 26705 - 26713. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jeong, X. Li, R. J. McEvilly, M. G. Rosenfeld, T. Lufkin, and J. L. R. Rubenstein Dlx genes pattern mammalian jaw primordium by regulating both lower jaw-specific and upper jaw-specific genetic programs Development, September 1, 2008; 135(17): 2905 - 2916. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Essalmani, A. Zaid, J. Marcinkiewicz, A. Chamberland, A. Pasquato, N. G. Seidah, and A. Prat In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate PNAS, April 15, 2008; 105(15): 5750 - 5755. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Zhang, Y. Huang, L.-Y. Qiu, J. Nickel, and W. Sebald von Willebrand Factor Type C Domain-containing Proteins Regulate Bone Morphogenetic Protein Signaling through Different Recognition Mechanisms J. Biol. Chem., July 6, 2007; 282(27): 20002 - 20014. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Koike, Y. Kassai, Y. Kouta, H. Miwa, M. Konishi, and N. Itoh Brorin, a Novel Secreted Bone Morphogenetic Protein Antagonist, Promotes Neurogenesis in Mouse Neural Precursor Cells J. Biol. Chem., May 25, 2007; 282(21): 15843 - 15850. [Abstract] [Full Text] [PDF] |
||||